Drugs that contain Lidocaine
1. Lidoderm patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5741510 | TEIKOKU PHARMA USA | Adhesive patch for applying analgesic medication to the skin |
Mar, 2014
(10 years ago) | |
| US5827529 | TEIKOKU PHARMA USA | External preparation for application to the skin containing lidocaine |
Oct, 2015
(8 years ago) | |
Market Authorisation Date: 19 March, 1999
Treatment: External preparation for application to the skin containing lidocaine-drug retaining layer placed on support and comprises adhesive gel base 1-10% by weight of lidocaine
Dosage: PATCH;TOPICAL
How can I launch a generic of LIDODERM before it's drug patent expiration?
More Information on Dosage
LIDODERM family patents
2. Ztlido patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11278623 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US11786455 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US9283174 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US10765749 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US9931403 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US9925264 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(7 years from now) | |
| US11793766 | SCILEX PHARMS | Non-aqueous patch for the relief of pain |
May, 2031
(7 years from now) | |
| US10765640 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(7 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Feb 28, 2021 |
Market Authorisation Date: 28 February, 2018
Treatment: Method for relieving the pain associated with post-herpetic neuralgia
Dosage: PATCH;TOPICAL
How can I launch a generic of ZTLIDO before it's drug patent expiration?
More Information on Dosage
ZTLIDO family patents